New Scale for Measuring Adherence to Antiseizure Medications
Author Information
Author(s): Sarah A. Alotaibi, Noura A. Alrukban, Layla N. Alanizy, Ahmad Saleh, Bshra A. Alsfouk
Primary Institution: Princess Nourah Bint Abdulrahman University
Hypothesis
The study aimed to develop and validate a scale that measures adherence levels to antiseizure medications and identifies reasons for non-adherence.
Conclusion
The ASASM-10 is a reliable and valid tool for evaluating patients' adherence to antiseizure medications.
Supporting Evidence
- The ASASM-10 showed a good internal consistency with a Cronbach’s alpha of 0.80.
- The test-retest reliability demonstrated a good correlation of ρ = 0.648.
- The correlation coefficient demonstrated a positive moderate correlation between ASASM-10 and MARS (ρ = 0.283).
- The scale was validated by three independent expert judges.
Takeaway
Researchers created a new questionnaire to help doctors understand how well patients are taking their epilepsy medications and why some might not be following their treatment.
Methodology
A cross-sectional study was conducted where patients completed the ASASM-10 and MARS scales to assess adherence.
Potential Biases
Self-report measures may introduce recall bias as participants might not accurately remember their adherence behaviors.
Limitations
The study used a convenience sampling method, which may limit the generalizability of the findings.
Participant Demographics
Participants included 162 patients with epilepsy, aged 18 to 84 years, with a mean age of 34.07 years; 56.2% were male.
Statistical Information
P-Value
< 0.001
Confidence Interval
0.718–0.857
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website